Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation-MedSci.cn

Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation

Zhao, XY; Xu, ZL; Mo, XD; Chen, YH; Lv, M; Cheng, YF; Chen, H; Chang, YJ; Xu, LP; Wang, Y; Zhang, XH; Liu, KY; Huang, XJ

Huang, XJ (通讯作者)，Peking Univ, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Natl Clin Res Ctr Hematol Dis,Inst Hematol, Beijing, Peoples R China.;Huang, XJ (通讯作者)，Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.

LEUKEMIA, 2022; 36 (1): 267

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation

科室

工具

服务